Skip to main content

Table 2 Disease severity and neuropsychological assessment in PD patients with different DWMH gradings

From: Systemic oxidative stress and cognitive function in Parkinson’s disease with different PWMH or DWMH lesions

DWMH gradings

Normal (n=24)

Mild (n=80)

Moderate to Severe (n=42)

P

P1

P2

P3

Gender (male, female)

11,13

30,50

23,19

0.185

0.484

0.610

0.084

Age (years, mean (SD))

55.37 (12.99)

63.06 (9.85)

69.61 (6.72)

0.001*

0.013*

0.001*

0.001*

HTN (number, percentage)

8 (33.3%)

25 (31.3%)

21 (50%)

0.117

0.848

0.193

0.043*

DM (number, percentage)

3 (12.5%)

10 (12.5%)

6 (14.3%)

0.959

1.000

0.840

0.782

Hypercholesterolemia (number, percentage)

3 (12.5%)

16 (20%)

12 (28.6%)

0.286

0.407

0.137

0.287

Smoking (number, percentage)

1 (4.2%)

3 (3.8%)

0

0.436

0.926

0.186

0.206

Medications (number, percentage)

8 (33.3%)

30 (37.5%)

14 (33.3%)

0.873

0.711

1.000

0.650

UPDRS total, mean (SD)

33.91 (23.26)

39.78 (23.05)

38.71 (29.19)

0.458

0.226

0.646

0.478

Modified Hoehn and Yahr scale, mean (SD)

1.71 (0.85)

1.92 (1.09)

2.09 (1.31)

0.706

0.674

0.404

0.583

Schwab and England ADL scale mean (SD)

87.36 (12.40)

82.89 (16.55)

81.00 (22.16)

0.583

0.281

0.528

0.741

MMSE, mean (SD)

25.47 (3.31)

25.32 (4.53)

22.14 (5.71)

0.002*

0.471

0.021*

0.001*

Neuropsychological battery

 Attention, mean (SD)

−0.24 (1.95)

−0.20 (2.03)

−1.57 (2.91)

0.020*

0.899

0.060

0.006*

 Executive function, mean (SD)

−1.31 (4.48)

− 0.60 (4.43)

−2.04 (4.69)

0.338

0.441

0.758

0.149

 Memory, mean (SD)

0.09 (1.96)

−0.34 (2.17)

−1.36 (2.77)

0.040*

0.620

0.028*

0.027*

 Language, mean (SD)

−0.54 (1.73)

−0.26 (2.43)

−1.30 (2.87)

0.127

0.431

0.298

0.051

 Visual-spatial, mean (SD)

−1.29 (1.79)

−0.56 (2.12)

−1.26 (2.67)

0.148

0.087

0.714

0.159

  1. Kruskal-Wallis H test was used for between-group comparisons of the three groups, and Mann-Whitney U test was used for between-two-group comparisons
  2. P Comparison of group 0, 1, and 2+ 3, P1 Comparison of group 0 and 1, P2 Comparison of group 0 and 2+ 3, P3 Comparison of group 1 and 2+ 3, SD Standard deviation, PD Parkinson’s disease, DWMH Deep white matter hyperintensity, HTN Hypertension, DM Diabetes Mellitus; Medications, was defined as Benzodiazepines
  3. *p< 0.05